ClinicalTrials.Veeva

Menu

Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection (Covid-Thelium)

U

University Hospital, Rouen

Status

Unknown

Conditions

Endothelial Dysfunction
Critically Ill
Thrombosis
Covid-19

Study type

Observational

Funder types

Other

Identifiers

NCT04357847
2020/097/OB

Details and patient eligibility

About

The outbreak at covid-19 is caused by the SARS-CoV-2 virus. This virus can be responsible for severe respiratory failure but also for extra-respiratory organ dysfunctions associated with severe inflammatory stress. The endothelium is an important structure of the blood vessels and is implicated in the organ failure of many patients admitted in intensive care units. It could be affected by the virus and its alteration may explain the organ dysfunction of covid-19 ICU patients as well as the thrombotic processes frequently obstructed in this infection.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all adult patients admitted in ICU for covid-19 disease within the past 24 hrs

Exclusion criteria

  • bactrial co-infection at admission
  • expected death within the next 24 hrs
  • pregnancy

Trial contacts and locations

1

Loading...

Central trial contact

emmanuel besnier, MD; thomas clavier, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems